These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34247209)

  • 21. A Case of Phenibut Directed Detoxification Leading to Toxicity During the COVID-19 Pandemic.
    Peterkin AF; Abraham R; Harris MTH
    J Addict Med; 2022 Sep-Oct 01; 16(5):602-605. PubMed ID: 35120058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Psychoactive Substances: Evolution in the Exchange of Information and Innovative Legal Responses in the European Union.
    Varì MR; Mannocchi G; Tittarelli R; Campanozzi LL; Nittari G; Feola A; Umani Ronchi F; Ricci G
    Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33238595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of new psychoactive substances to mimic prescription drugs: The trend in France.
    Batisse A; Eiden C; Peyriere H; Djezzar S;
    Neurotoxicology; 2020 Jul; 79():20-24. PubMed ID: 32240674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New psychoactive substances: concerted efforts and common legislative answers for stemming a growing health hazard.
    Zaami S
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9681-9690. PubMed ID: 31799633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.
    Helander A; Beck O; Hägerkvist R; Hultén P
    Scand J Clin Lab Invest; 2013 Aug; 73(5):400-6. PubMed ID: 23692208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persons with Substance Abuse Disorders and Other Addictions: Coping with the COVID-19 Pandemic.
    Fabelo-Roche JR; Iglesias-Moré S; Gómez-García AM
    MEDICC Rev; 2021 Apr; 23(2):55. PubMed ID: 33974609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicology in international drug control-Prioritizing the most harmful, persistent and prevalent substances.
    Ifeagwu SC; Raithelhuber M; Crean C; Gerostamoulos D; Chung H; Tettey JN
    Forensic Sci Int; 2017 May; 274():2-6. PubMed ID: 27899215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New psychoactive substances (NPS) prevalence over LSD in blotter seized in State of Santa Catarina, Brazil: A six-year retrospective study.
    de Souza Boff B; Silveira Filho J; Nonemacher K; Driessen Schroeder S; Dutra Arbo M; Rezin KZ
    Forensic Sci Int; 2020 Jan; 306():110002. PubMed ID: 31864775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan.
    Tanibuchi Y; Matsumoto T; Funada D; Shimane T
    Neuropsychopharmacol Rep; 2018 Dec; 38(4):189-196. PubMed ID: 30341809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [COVID-19 impact on substance use and behaviors with addictive potential: Spanish Observatory on Drugs and Addictions survey.].
    Llorens N; Brime B; Molina M
    Rev Esp Salud Publica; 2021 Nov; 95():. PubMed ID: 34853293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The benzodiazepines--use and abuse.
    Marks J
    Arzneimittelforschung; 1980; 30(5a):898-901. PubMed ID: 6106493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recommendations about the Use of Psychotropic Medications during the COVID-19 Pandemic].
    Andrade G; Simões do Couto F; Câmara-Pestana L
    Acta Med Port; 2020 Oct; 33(10):693-702. PubMed ID: 32705981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
    Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
    BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
    Gray R; Bressington D; Hughes E; Ivanecka A
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
    Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
    Ann Agric Environ Med; 2012; 19(4):857-70. PubMed ID: 23311820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Psychoactive Substances in Pediatric Patients.
    Warrick BJ; Tataru AP; Gerona R
    Pediatr Clin North Am; 2017 Dec; 64(6):1223-1241. PubMed ID: 29173782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights Into Mixing Fentanyl and Benzodiazepines From Canadian Drug Seizures.
    Pardo B
    JAMA Psychiatry; 2022 Jan; 79(1):81-83. PubMed ID: 34787646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving Public Access to COVID-19 Pandemic Data in Indonesia for Better Public Health Response.
    Januraga PP; Harjana NPA
    Front Public Health; 2020; 8():563150. PubMed ID: 33330311
    [No Abstract]   [Full Text] [Related]  

  • 39. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
    [No Abstract]   [Full Text] [Related]  

  • 40. [Synthetic Drugs - An Overview of Important and Newly Emerging Substances].
    Betzler F; Heinz A; Köhler S
    Fortschr Neurol Psychiatr; 2016 Nov; 84(11):690-698. PubMed ID: 27846654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.